Oncosem Announces 1,200% Bonus Share Capital Increase

Oncosem has decided to increase its paid-in capital from the current 23.85 million TL to 310.05 million TL through a 1,200% bonus share issuance, funded from internal resources. This move aims to strengthen the company's financial structure. The bonus share capital increase allows existing shareholders to receive new shares without any additional payment. The transaction stems from an increase in the company's equity items and is generally viewed positively by investors. Oncosem's step signals positive developments regarding its growth strategy and financial health. Investors should evaluate the effects of the bonus share capital increase on the stock price. This is not investment advice.

📊 ONCSM — Piyasa Yorumu

▼ down · 70%

The news announces a very high free-share capital increase of 1,200%. Such rates typically dilute the per-share value and may create selling pressure in the short term. Technical indicators are in overbought territory (RSI 80.9), and the price is well above moving averages, increasing the likelihood of a correction. Although the MACD is positive, overvaluation and the uncertainty generated by the news support a short-term bearish trend. I believe investors may tend to take profits.

RSI 14

80.9

MACD

5.51

24h Δ

6.70%

Canlı Grafikler